CCL18 and urinary bladder carcinoma: In bladder cancer, activation of CCR8 by CCL18 causes the migration and invasion of tumor cells, as well as increased expression of vascular endothelial growth factor (VEGF)-C, which then causes lymphangiogenesis [22].